Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IPO
Biotech
Boundless Bio eyes $88M offering as spring IPO market blooms
Boundless Bio has set out its IPO pricing ambitions at the more modest end of the year’s offerings.
James Waldron
Mar 21, 2024 8:50am
J&J-allied bio files IPO to take fight to BMS, Roche and more
Mar 18, 2024 7:15am
Boundless Bio bumps IPO market back to life
Mar 6, 2024 5:20pm
Agiliti to go private in $2.5B buyout deal
Feb 27, 2024 11:19am
Kyverna CEO: 'We're in the next phase of medicine'
Feb 9, 2024 1:57pm
Metagenomi, Telomir offer double test case for preclinical IPOs
Feb 9, 2024 7:00am